Drugs that contain Colchicine

1. List of Colcrys drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7964648 TAKEDA PHARMS USA Methods for concomitant administration of colchicine and a second active agent
Oct, 2028

(5 years from now)

US7964647 TAKEDA PHARMS USA Colchicine compositions and methods
Oct, 2028

(5 years from now)

US8093297 TAKEDA PHARMS USA Methods for concomitant administration of colchicine and a second active agent
Oct, 2028

(5 years from now)

US8097655 TAKEDA PHARMS USA Methods for concomitant administration of colchicine and macrolide antibiotics
Oct, 2028

(5 years from now)

US8415396 TAKEDA PHARMS USA Colchine compositions and methods
Oct, 2028

(5 years from now)

US8093296 TAKEDA PHARMS USA Methods for concomitant administration of colchicine and macrolide antibiotics
Oct, 2028

(5 years from now)

US8093298 TAKEDA PHARMS USA Methods for concomitant administration of colchicine and macrolide antibiotics
Oct, 2028

(5 years from now)

US8415395 TAKEDA PHARMS USA Colchicine compositions and methods
Oct, 2028

(5 years from now)

US7981938 TAKEDA PHARMS USA Colchicine compositions and methods
Oct, 2028

(5 years from now)

US7935731 TAKEDA PHARMS USA Methods for concomitant administration of colchicine and macrolide antibiotics
Dec, 2028

(5 years from now)

US7619004 TAKEDA PHARMS USA Methods for concomitant administration of colchicine and macrolide antibiotics
Dec, 2028

(5 years from now)

US7601758 TAKEDA PHARMS USA Methods for concomitant administration of colchicine and macrolide antibiotics in the treatment of gout flares
Feb, 2029

(6 years from now)

US7820681 TAKEDA PHARMS USA Methods for concomitant administration of colchicine and a second active agent
Feb, 2029

(6 years from now)

US7915269 TAKEDA PHARMS USA Methods for concomitant administration of colchicine and a second active agent
Feb, 2029

(6 years from now)

US7906519 TAKEDA PHARMS USA Methods for concomitant administration of colchicine and a second active agent
Feb, 2029

(6 years from now)

US8440721 TAKEDA PHARMS USA Methods for concomitant administration of colchicine and a second active agent
Feb, 2029

(6 years from now)

US8440722 TAKEDA PHARMS USA Methods for concomitant administration of colchicine and a second active agent
Feb, 2029

(6 years from now)

Market Authorisation Date: 29 July, 2009

Treatment: For the treatment and prophylaxis of gout flares & the treatment of familial mediterranean fever; Method of treating gout flares; Method of using colchicine for the prophylaxis of gout flares; Method of administering colchicine to familial mediterranean fever patients; A method for treatment of gout flares during prophylaxis

Dosage: TABLET;ORAL

How can I launch a generic of COLCRYS before it's patent expiration?
More Information on Dosage

2. List of Gloperba drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10383820 ROMEG Colchicine drug-to-drug interactions
Nov, 2036

(13 years from now)

US10383821 ROMEG Colchicine drug-to-drug interactions
Nov, 2036

(13 years from now)

US9907751 ROMEG Composition and method of use of colchicine oral liquid
Nov, 2036

(13 years from now)

US10226423 ROMEG Colchicine drug-to-drug interactions
Dec, 2037

(14 years from now)

Market Authorisation Date: 30 January, 2019

Treatment: A method of prophylactic treatment of gout flares in adults comprises administering to a patient a liquid colchicine oral solution

Dosage: SOLUTION;ORAL

How can I launch a generic of GLOPERBA before it's patent expiration?
More Information on Dosage

3. List of Mitigare drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9399036 HIKMA INTL PHARMS Methods of colchicine administration
Aug, 2033

(10 years from now)

US9675613 HIKMA INTL PHARMS Methods of colchicine administration
Aug, 2033

(10 years from now)

US8927607 HIKMA INTL PHARMS Methods of colchicine administration
Aug, 2033

(10 years from now)

US9555029 HIKMA INTL PHARMS Methods of colchicine administration
Aug, 2033

(10 years from now)

US9789108 HIKMA INTL PHARMS Methods of colchicine administration
Aug, 2033

(10 years from now)

Market Authorisation Date: 26 September, 2014

Treatment: Method of using colchicine for the prophylaxis of gout flares

Dosage: CAPSULE;ORAL

How can I launch a generic of MITIGARE before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic